Attached files

file filename
10-K - FORM 10-K - GENOMIC HEALTH INCf58029e10vk.htm
EX-21.1 - EX-21.1 - GENOMIC HEALTH INCf58029exv21w1.htm
EX-12.1 - EX-12.1 - GENOMIC HEALTH INCf58029exv12w1.htm
EX-31.1 - EX-31.1 - GENOMIC HEALTH INCf58029exv31w1.htm
EX-32.1 - EX-32.1 - GENOMIC HEALTH INCf58029exv32w1.htm
EX-32.2 - EX-32.2 - GENOMIC HEALTH INCf58029exv32w2.htm
EX-31.2 - EX-31.2 - GENOMIC HEALTH INCf58029exv31w2.htm
EX-10.14 - EX-10.14 - GENOMIC HEALTH INCf58029exv10w14.htm
EX-10.13 - EX-10.13 - GENOMIC HEALTH INCf58029exv10w13.htm
EX-10.15 - EX-10.15 - GENOMIC HEALTH INCf58029exv10w15.htm
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
     We consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-128805) pertaining to the 2005 Stock Incentive Plan and 2001 Stock Incentive Plan of Genomic Health, Inc., the Registration Statement on Form S-8 (No. 333-163006) pertaining to the 2005 Stock Incentive Plan of Genomic Health, Inc., and the Registration Statement on Form S-3 (No. 333-167868) of Genomic Health, Inc. of our reports dated March 11, 2011, with respect to the consolidated financial statements and schedule of Genomic Health, Inc., and the effectiveness of internal control over financial reporting of Genomic Health, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2010.
/s/ Ernst & Young LLP
Palo Alto, California
March 11, 2011